nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—Naftifine—Diphenhydramine—atopic dermatitis	0.323	1	CrCrCtD
Cinacalcet—CYP3A4—Pimecrolimus—atopic dermatitis	0.0733	0.158	CbGbCtD
Cinacalcet—CYP1A2—Diphenhydramine—atopic dermatitis	0.0609	0.132	CbGbCtD
Cinacalcet—CYP2D6—Loratadine—atopic dermatitis	0.0502	0.108	CbGbCtD
Cinacalcet—CYP2D6—Diphenhydramine—atopic dermatitis	0.0502	0.108	CbGbCtD
Cinacalcet—CYP3A4—Tacrolimus—atopic dermatitis	0.0436	0.0942	CbGbCtD
Cinacalcet—CYP3A4—Loratadine—atopic dermatitis	0.0319	0.0689	CbGbCtD
Cinacalcet—CYP3A4—Methylprednisolone—atopic dermatitis	0.0292	0.063	CbGbCtD
Cinacalcet—CYP3A4—Triamcinolone—atopic dermatitis	0.0221	0.0478	CbGbCtD
Cinacalcet—CYP3A4—Betamethasone—atopic dermatitis	0.019	0.041	CbGbCtD
Cinacalcet—CYP3A4—Prednisolone—atopic dermatitis	0.0187	0.0404	CbGbCtD
Cinacalcet—CYP3A4—Hydrocortisone—atopic dermatitis	0.0177	0.0383	CbGbCtD
Cinacalcet—CYP3A4—Prednisone—atopic dermatitis	0.0177	0.0382	CbGbCtD
Cinacalcet—CYP2D6—Dexamethasone—atopic dermatitis	0.0174	0.0375	CbGbCtD
Cinacalcet—CYP3A4—Dexamethasone—atopic dermatitis	0.011	0.0238	CbGbCtD
Cinacalcet—CASR—neck—atopic dermatitis	0.00463	0.685	CbGeAlD
Cinacalcet—CASR—head—atopic dermatitis	0.00195	0.289	CbGeAlD
Cinacalcet—CASR—G alpha (i) signalling events—CCL27—atopic dermatitis	0.0011	0.057	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CCL22—atopic dermatitis	0.000746	0.0387	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—NPS—atopic dermatitis	0.000693	0.0359	CbGpPWpGaD
Cinacalcet—CASR—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000693	0.0359	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CCL27—atopic dermatitis	0.000665	0.0345	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000647	0.0336	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00062	0.0321	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00062	0.0321	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CCL17—atopic dermatitis	0.000597	0.0309	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000566	0.0293	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CCL11—atopic dermatitis	0.000481	0.0249	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000457	0.0237	CbGpPWpGaD
Cinacalcet—Myalgia—Tacrolimus—atopic dermatitis	0.000436	0.00231	CcSEcCtD
Cinacalcet—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000435	0.00231	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000433	0.0023	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000429	0.00228	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.000426	0.00226	CcSEcCtD
Cinacalcet—Diarrhoea—Loratadine—atopic dermatitis	0.000419	0.00222	CcSEcCtD
Cinacalcet—Infection—Tacrolimus—atopic dermatitis	0.000415	0.0022	CcSEcCtD
Cinacalcet—Abdominal pain—Mometasone—atopic dermatitis	0.000415	0.0022	CcSEcCtD
Cinacalcet—Body temperature increased—Mometasone—atopic dermatitis	0.000415	0.0022	CcSEcCtD
Cinacalcet—Nervous system disorder—Tacrolimus—atopic dermatitis	0.00041	0.00217	CcSEcCtD
Cinacalcet—Skin disorder—Tacrolimus—atopic dermatitis	0.000406	0.00215	CcSEcCtD
Cinacalcet—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000405	0.00215	CcSEcCtD
Cinacalcet—Dizziness—Loratadine—atopic dermatitis	0.000405	0.00215	CcSEcCtD
Cinacalcet—Cardiac failure—Prednisone—atopic dermatitis	0.000404	0.00214	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.000401	0.00213	CcSEcCtD
Cinacalcet—Anorexia—Tacrolimus—atopic dermatitis	0.000398	0.00211	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Prednisone—atopic dermatitis	0.000395	0.00209	CcSEcCtD
Cinacalcet—CASR—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000394	0.0204	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—CCR3—atopic dermatitis	0.000392	0.0203	CbGpPWpGaD
Cinacalcet—Hypotension—Tacrolimus—atopic dermatitis	0.000391	0.00207	CcSEcCtD
Cinacalcet—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000389	0.00206	CcSEcCtD
Cinacalcet—Vomiting—Loratadine—atopic dermatitis	0.000389	0.00206	CcSEcCtD
Cinacalcet—Rash—Loratadine—atopic dermatitis	0.000386	0.00205	CcSEcCtD
Cinacalcet—Dermatitis—Loratadine—atopic dermatitis	0.000385	0.00204	CcSEcCtD
Cinacalcet—Headache—Loratadine—atopic dermatitis	0.000383	0.00203	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCL22—atopic dermatitis	0.000383	0.0199	CbGpPWpGaD
Cinacalcet—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000381	0.00202	CcSEcCtD
Cinacalcet—Asthenia—Mometasone—atopic dermatitis	0.000377	0.002	CcSEcCtD
Cinacalcet—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000376	0.002	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CCL27—atopic dermatitis	0.000376	0.0195	CbGpPWpGaD
Cinacalcet—Paraesthesia—Tacrolimus—atopic dermatitis	0.000375	0.00199	CcSEcCtD
Cinacalcet—Dyspnoea—Tacrolimus—atopic dermatitis	0.000373	0.00198	CcSEcCtD
Cinacalcet—Pruritus—Mometasone—atopic dermatitis	0.000372	0.00197	CcSEcCtD
Cinacalcet—Dyspepsia—Tacrolimus—atopic dermatitis	0.000368	0.00195	CcSEcCtD
Cinacalcet—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000364	0.00193	CcSEcCtD
Cinacalcet—Nausea—Loratadine—atopic dermatitis	0.000363	0.00193	CcSEcCtD
Cinacalcet—Decreased appetite—Tacrolimus—atopic dermatitis	0.000363	0.00193	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000361	0.00191	CcSEcCtD
Cinacalcet—Fatigue—Tacrolimus—atopic dermatitis	0.00036	0.00191	CcSEcCtD
Cinacalcet—Diarrhoea—Mometasone—atopic dermatitis	0.000359	0.00191	CcSEcCtD
Cinacalcet—Constipation—Tacrolimus—atopic dermatitis	0.000357	0.0019	CcSEcCtD
Cinacalcet—CASR—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000355	0.0184	CbGpPWpGaD
Cinacalcet—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00035	0.00185	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—TAC1—atopic dermatitis	0.000349	0.0181	CbGpPWpGaD
Cinacalcet—CASR—GPCR ligand binding—NPS—atopic dermatitis	0.000349	0.0181	CbGpPWpGaD
Cinacalcet—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000347	0.00184	CcSEcCtD
Cinacalcet—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000346	0.00184	CcSEcCtD
Cinacalcet—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000345	0.00183	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—CXCR3—atopic dermatitis	0.000343	0.0178	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000342	0.00181	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCL27—atopic dermatitis	0.000341	0.0177	CbGpPWpGaD
Cinacalcet—Arrhythmia—Prednisolone—atopic dermatitis	0.000336	0.00178	CcSEcCtD
Cinacalcet—Vomiting—Mometasone—atopic dermatitis	0.000334	0.00177	CcSEcCtD
Cinacalcet—Urticaria—Tacrolimus—atopic dermatitis	0.000332	0.00176	CcSEcCtD
Cinacalcet—Immune system disorder—Hydrocortisone—atopic dermatitis	0.000331	0.00176	CcSEcCtD
Cinacalcet—Rash—Mometasone—atopic dermatitis	0.000331	0.00176	CcSEcCtD
Cinacalcet—Dermatitis—Mometasone—atopic dermatitis	0.000331	0.00175	CcSEcCtD
Cinacalcet—Abdominal pain—Tacrolimus—atopic dermatitis	0.00033	0.00175	CcSEcCtD
Cinacalcet—Body temperature increased—Tacrolimus—atopic dermatitis	0.00033	0.00175	CcSEcCtD
Cinacalcet—Headache—Mometasone—atopic dermatitis	0.000329	0.00174	CcSEcCtD
Cinacalcet—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000328	0.00174	CcSEcCtD
Cinacalcet—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000327	0.00173	CcSEcCtD
Cinacalcet—Malnutrition—Hydrocortisone—atopic dermatitis	0.000319	0.00169	CcSEcCtD
Cinacalcet—Nausea—Mometasone—atopic dermatitis	0.000312	0.00165	CcSEcCtD
Cinacalcet—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000311	0.00165	CcSEcCtD
Cinacalcet—Arrhythmia—Triamcinolone—atopic dermatitis	0.000309	0.00164	CcSEcCtD
Cinacalcet—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000308	0.00163	CcSEcCtD
Cinacalcet—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000308	0.00163	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCL17—atopic dermatitis	0.000306	0.0159	CbGpPWpGaD
Cinacalcet—Depression—Prednisone—atopic dermatitis	0.000303	0.00161	CcSEcCtD
Cinacalcet—Malnutrition—Methylprednisolone—atopic dermatitis	0.0003	0.00159	CcSEcCtD
Cinacalcet—Asthenia—Tacrolimus—atopic dermatitis	0.0003	0.00159	CcSEcCtD
Cinacalcet—Angioedema—Prednisolone—atopic dermatitis	0.000299	0.00158	CcSEcCtD
Cinacalcet—Pruritus—Tacrolimus—atopic dermatitis	0.000296	0.00157	CcSEcCtD
Cinacalcet—Angioedema—Hydrocortisone—atopic dermatitis	0.000292	0.00155	CcSEcCtD
Cinacalcet—Diarrhoea—Tacrolimus—atopic dermatitis	0.000286	0.00152	CcSEcCtD
Cinacalcet—Convulsion—Prednisolone—atopic dermatitis	0.000283	0.0015	CcSEcCtD
Cinacalcet—Hypertension—Prednisolone—atopic dermatitis	0.000282	0.0015	CcSEcCtD
Cinacalcet—Arrhythmia—Dexamethasone—atopic dermatitis	0.00028	0.00149	CcSEcCtD
Cinacalcet—Arrhythmia—Betamethasone—atopic dermatitis	0.00028	0.00149	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—CXCL10—atopic dermatitis	0.000277	0.0144	CbGpPWpGaD
Cinacalcet—Convulsion—Hydrocortisone—atopic dermatitis	0.000277	0.00147	CcSEcCtD
Cinacalcet—Dizziness—Tacrolimus—atopic dermatitis	0.000276	0.00147	CcSEcCtD
Cinacalcet—Hypertension—Hydrocortisone—atopic dermatitis	0.000276	0.00146	CcSEcCtD
Cinacalcet—Angioedema—Triamcinolone—atopic dermatitis	0.000275	0.00146	CcSEcCtD
Cinacalcet—Angioedema—Methylprednisolone—atopic dermatitis	0.000274	0.00145	CcSEcCtD
Cinacalcet—Myalgia—Hydrocortisone—atopic dermatitis	0.000272	0.00144	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.00027	0.00143	CcSEcCtD
Cinacalcet—Vomiting—Tacrolimus—atopic dermatitis	0.000266	0.00141	CcSEcCtD
Cinacalcet—Rash—Tacrolimus—atopic dermatitis	0.000264	0.0014	CcSEcCtD
Cinacalcet—Dermatitis—Tacrolimus—atopic dermatitis	0.000263	0.0014	CcSEcCtD
Cinacalcet—CYP1A2—Estrogen Receptor Pathway—PPARA—atopic dermatitis	0.000263	0.0136	CbGpPWpGaD
Cinacalcet—Cough—Triamcinolone—atopic dermatitis	0.000262	0.00139	CcSEcCtD
Cinacalcet—Headache—Tacrolimus—atopic dermatitis	0.000262	0.00139	CcSEcCtD
Cinacalcet—Convulsion—Triamcinolone—atopic dermatitis	0.000261	0.00138	CcSEcCtD
Cinacalcet—Convulsion—Methylprednisolone—atopic dermatitis	0.00026	0.00138	CcSEcCtD
Cinacalcet—Hypertension—Triamcinolone—atopic dermatitis	0.00026	0.00138	CcSEcCtD
Cinacalcet—Hypertension—Methylprednisolone—atopic dermatitis	0.000259	0.00137	CcSEcCtD
Cinacalcet—Infection—Hydrocortisone—atopic dermatitis	0.000259	0.00137	CcSEcCtD
Cinacalcet—Myalgia—Triamcinolone—atopic dermatitis	0.000256	0.00136	CcSEcCtD
Cinacalcet—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000256	0.00136	CcSEcCtD
Cinacalcet—Arthralgia—Methylprednisolone—atopic dermatitis	0.000256	0.00135	CcSEcCtD
Cinacalcet—Myalgia—Methylprednisolone—atopic dermatitis	0.000256	0.00135	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000254	0.00135	CcSEcCtD
Cinacalcet—Skin disorder—Hydrocortisone—atopic dermatitis	0.000253	0.00134	CcSEcCtD
Cinacalcet—Angioedema—Dexamethasone—atopic dermatitis	0.000249	0.00132	CcSEcCtD
Cinacalcet—Angioedema—Betamethasone—atopic dermatitis	0.000249	0.00132	CcSEcCtD
Cinacalcet—Anorexia—Hydrocortisone—atopic dermatitis	0.000249	0.00132	CcSEcCtD
Cinacalcet—Nausea—Tacrolimus—atopic dermatitis	0.000248	0.00132	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCL11—atopic dermatitis	0.000247	0.0128	CbGpPWpGaD
Cinacalcet—Immune system disorder—Prednisone—atopic dermatitis	0.000247	0.00131	CcSEcCtD
Cinacalcet—Arrhythmia—Prednisone—atopic dermatitis	0.000244	0.00129	CcSEcCtD
Cinacalcet—Infection—Triamcinolone—atopic dermatitis	0.000244	0.00129	CcSEcCtD
Cinacalcet—Hypotension—Hydrocortisone—atopic dermatitis	0.000244	0.00129	CcSEcCtD
Cinacalcet—Infection—Methylprednisolone—atopic dermatitis	0.000243	0.00129	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—FCER2—atopic dermatitis	0.000243	0.0126	CbGpPWpGaD
Cinacalcet—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.00024	0.00127	CcSEcCtD
Cinacalcet—Paraesthesia—Prednisolone—atopic dermatitis	0.00024	0.00127	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—CCL5—atopic dermatitis	0.000238	0.0124	CbGpPWpGaD
Cinacalcet—Skin disorder—Methylprednisolone—atopic dermatitis	0.000238	0.00126	CcSEcCtD
Cinacalcet—Malnutrition—Prednisone—atopic dermatitis	0.000238	0.00126	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000238	0.00126	CcSEcCtD
Cinacalcet—Convulsion—Betamethasone—atopic dermatitis	0.000236	0.00125	CcSEcCtD
Cinacalcet—Convulsion—Dexamethasone—atopic dermatitis	0.000236	0.00125	CcSEcCtD
Cinacalcet—Hypertension—Dexamethasone—atopic dermatitis	0.000236	0.00125	CcSEcCtD
Cinacalcet—Hypertension—Betamethasone—atopic dermatitis	0.000236	0.00125	CcSEcCtD
Cinacalcet—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000234	0.00124	CcSEcCtD
Cinacalcet—Myalgia—Betamethasone—atopic dermatitis	0.000232	0.00123	CcSEcCtD
Cinacalcet—Myalgia—Dexamethasone—atopic dermatitis	0.000232	0.00123	CcSEcCtD
Cinacalcet—Dyspepsia—Hydrocortisone—atopic dermatitis	0.00023	0.00122	CcSEcCtD
Cinacalcet—Hypotension—Methylprednisolone—atopic dermatitis	0.000229	0.00121	CcSEcCtD
Cinacalcet—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000227	0.0012	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CCL22—atopic dermatitis	0.000226	0.0117	CbGpPWpGaD
Cinacalcet—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000225	0.00119	CcSEcCtD
Cinacalcet—Fatigue—Hydrocortisone—atopic dermatitis	0.000225	0.00119	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000224	0.00119	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000223	0.00118	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CCR3—atopic dermatitis	0.000222	0.0115	CbGpPWpGaD
Cinacalcet—Infection—Dexamethasone—atopic dermatitis	0.000221	0.00117	CcSEcCtD
Cinacalcet—Infection—Betamethasone—atopic dermatitis	0.000221	0.00117	CcSEcCtD
Cinacalcet—Paraesthesia—Triamcinolone—atopic dermatitis	0.00022	0.00117	CcSEcCtD
Cinacalcet—Paraesthesia—Methylprednisolone—atopic dermatitis	0.00022	0.00117	CcSEcCtD
Cinacalcet—Anaemia—Prednisone—atopic dermatitis	0.00022	0.00116	CcSEcCtD
Cinacalcet—Dyspnoea—Triamcinolone—atopic dermatitis	0.000219	0.00116	CcSEcCtD
Cinacalcet—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000218	0.00116	CcSEcCtD
Cinacalcet—Nervous system disorder—Betamethasone—atopic dermatitis	0.000218	0.00116	CcSEcCtD
Cinacalcet—Angioedema—Prednisone—atopic dermatitis	0.000217	0.00115	CcSEcCtD
Cinacalcet—Dyspepsia—Triamcinolone—atopic dermatitis	0.000216	0.00115	CcSEcCtD
Cinacalcet—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000216	0.00114	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—CCR5—atopic dermatitis	0.000215	0.0111	CbGpPWpGaD
Cinacalcet—CASR—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000214	0.0111	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000213	0.00113	CcSEcCtD
Cinacalcet—Anorexia—Betamethasone—atopic dermatitis	0.000212	0.00113	CcSEcCtD
Cinacalcet—Anorexia—Dexamethasone—atopic dermatitis	0.000212	0.00113	CcSEcCtD
Cinacalcet—Urticaria—Prednisolone—atopic dermatitis	0.000212	0.00112	CcSEcCtD
Cinacalcet—Fatigue—Triamcinolone—atopic dermatitis	0.000212	0.00112	CcSEcCtD
Cinacalcet—Fatigue—Methylprednisolone—atopic dermatitis	0.000211	0.00112	CcSEcCtD
Cinacalcet—Hypotension—Dexamethasone—atopic dermatitis	0.000208	0.0011	CcSEcCtD
Cinacalcet—Hypotension—Betamethasone—atopic dermatitis	0.000208	0.0011	CcSEcCtD
Cinacalcet—Urticaria—Hydrocortisone—atopic dermatitis	0.000207	0.0011	CcSEcCtD
Cinacalcet—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000206	0.00109	CcSEcCtD
Cinacalcet—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000206	0.00109	CcSEcCtD
Cinacalcet—Convulsion—Prednisone—atopic dermatitis	0.000206	0.00109	CcSEcCtD
Cinacalcet—Hypertension—Prednisone—atopic dermatitis	0.000205	0.00109	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000203	0.00108	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000203	0.00108	CcSEcCtD
Cinacalcet—Myalgia—Prednisone—atopic dermatitis	0.000202	0.00107	CcSEcCtD
Cinacalcet—Arthralgia—Prednisone—atopic dermatitis	0.000202	0.00107	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CCL27—atopic dermatitis	0.000202	0.0105	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CCR3—atopic dermatitis	0.000201	0.0104	CbGpPWpGaD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000201	0.00107	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.0002	0.00106	CcSEcCtD
Cinacalcet—Paraesthesia—Betamethasone—atopic dermatitis	0.0002	0.00106	CcSEcCtD
Cinacalcet—Paraesthesia—Dexamethasone—atopic dermatitis	0.0002	0.00106	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—NPS—atopic dermatitis	0.000197	0.0102	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—TAC1—atopic dermatitis	0.000197	0.0102	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Prednisolone—atopic dermatitis	0.000197	0.00104	CcSEcCtD
Cinacalcet—Dyspepsia—Dexamethasone—atopic dermatitis	0.000196	0.00104	CcSEcCtD
Cinacalcet—Dyspepsia—Betamethasone—atopic dermatitis	0.000196	0.00104	CcSEcCtD
Cinacalcet—Urticaria—Triamcinolone—atopic dermatitis	0.000195	0.00103	CcSEcCtD
Cinacalcet—Urticaria—Methylprednisolone—atopic dermatitis	0.000195	0.00103	CcSEcCtD
Cinacalcet—Body temperature increased—Triamcinolone—atopic dermatitis	0.000194	0.00103	CcSEcCtD
Cinacalcet—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000194	0.00103	CcSEcCtD
Cinacalcet—Decreased appetite—Betamethasone—atopic dermatitis	0.000194	0.00103	CcSEcCtD
Cinacalcet—Decreased appetite—Dexamethasone—atopic dermatitis	0.000194	0.00103	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000194	0.01	CbGpPWpGaD
Cinacalcet—Infection—Prednisone—atopic dermatitis	0.000193	0.00102	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000192	0.00102	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000192	0.00102	CcSEcCtD
Cinacalcet—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000192	0.00102	CcSEcCtD
Cinacalcet—Fatigue—Dexamethasone—atopic dermatitis	0.000192	0.00102	CcSEcCtD
Cinacalcet—Fatigue—Betamethasone—atopic dermatitis	0.000192	0.00102	CcSEcCtD
Cinacalcet—Nervous system disorder—Prednisone—atopic dermatitis	0.00019	0.00101	CcSEcCtD
Cinacalcet—Skin disorder—Prednisone—atopic dermatitis	0.000188	0.000999	CcSEcCtD
Cinacalcet—Asthenia—Hydrocortisone—atopic dermatitis	0.000187	0.000992	CcSEcCtD
Cinacalcet—Anorexia—Prednisone—atopic dermatitis	0.000185	0.000981	CcSEcCtD
Cinacalcet—Pruritus—Hydrocortisone—atopic dermatitis	0.000184	0.000978	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—IL5—atopic dermatitis	0.000184	0.00952	CbGpPWpGaD
Cinacalcet—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000182	0.000966	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000182	0.000966	CcSEcCtD
Cinacalcet—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000181	0.000959	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CCL17—atopic dermatitis	0.000181	0.00938	CbGpPWpGaD
Cinacalcet—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.00018	0.000957	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—TAC1—atopic dermatitis	0.000179	0.0093	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—NPS—atopic dermatitis	0.000179	0.0093	CbGpPWpGaD
Cinacalcet—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000178	0.000946	CcSEcCtD
Cinacalcet—Urticaria—Dexamethasone—atopic dermatitis	0.000177	0.000938	CcSEcCtD
Cinacalcet—Urticaria—Betamethasone—atopic dermatitis	0.000177	0.000938	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000177	0.000937	CcSEcCtD
Cinacalcet—Dizziness—Prednisolone—atopic dermatitis	0.000177	0.000936	CcSEcCtD
Cinacalcet—Asthenia—Triamcinolone—atopic dermatitis	0.000176	0.000934	CcSEcCtD
Cinacalcet—Abdominal pain—Betamethasone—atopic dermatitis	0.000176	0.000934	CcSEcCtD
Cinacalcet—Body temperature increased—Betamethasone—atopic dermatitis	0.000176	0.000934	CcSEcCtD
Cinacalcet—Abdominal pain—Dexamethasone—atopic dermatitis	0.000176	0.000934	CcSEcCtD
Cinacalcet—Body temperature increased—Dexamethasone—atopic dermatitis	0.000176	0.000934	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CXCR3—atopic dermatitis	0.000176	0.00912	CbGpPWpGaD
Cinacalcet—Asthenia—Methylprednisolone—atopic dermatitis	0.000176	0.000932	CcSEcCtD
Cinacalcet—Paraesthesia—Prednisone—atopic dermatitis	0.000174	0.000924	CcSEcCtD
Cinacalcet—Pruritus—Triamcinolone—atopic dermatitis	0.000174	0.000921	CcSEcCtD
Cinacalcet—Pruritus—Methylprednisolone—atopic dermatitis	0.000173	0.000919	CcSEcCtD
Cinacalcet—CYP2D6—head—atopic dermatitis	0.000173	0.0256	CbGeAlD
Cinacalcet—Dizziness—Hydrocortisone—atopic dermatitis	0.000172	0.000914	CcSEcCtD
Cinacalcet—Dyspepsia—Prednisone—atopic dermatitis	0.000171	0.000906	CcSEcCtD
Cinacalcet—Decreased appetite—Prednisone—atopic dermatitis	0.000169	0.000894	CcSEcCtD
Cinacalcet—Rash—Prednisolone—atopic dermatitis	0.000168	0.000893	CcSEcCtD
Cinacalcet—Dermatitis—Prednisolone—atopic dermatitis	0.000168	0.000892	CcSEcCtD
Cinacalcet—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000168	0.000889	CcSEcCtD
Cinacalcet—Fatigue—Prednisone—atopic dermatitis	0.000167	0.000887	CcSEcCtD
Cinacalcet—Headache—Prednisolone—atopic dermatitis	0.000167	0.000887	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—IL5—atopic dermatitis	0.000167	0.00865	CbGpPWpGaD
Cinacalcet—Constipation—Prednisone—atopic dermatitis	0.000166	0.00088	CcSEcCtD
Cinacalcet—Vomiting—Hydrocortisone—atopic dermatitis	0.000166	0.000879	CcSEcCtD
Cinacalcet—Rash—Hydrocortisone—atopic dermatitis	0.000164	0.000872	CcSEcCtD
Cinacalcet—Dermatitis—Hydrocortisone—atopic dermatitis	0.000164	0.000871	CcSEcCtD
Cinacalcet—Headache—Hydrocortisone—atopic dermatitis	0.000163	0.000866	CcSEcCtD
Cinacalcet—Dizziness—Triamcinolone—atopic dermatitis	0.000162	0.000861	CcSEcCtD
Cinacalcet—Dizziness—Methylprednisolone—atopic dermatitis	0.000162	0.000859	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—KIF3A—atopic dermatitis	0.000161	0.00836	CbGpPWpGaD
Cinacalcet—Asthenia—Betamethasone—atopic dermatitis	0.00016	0.000847	CcSEcCtD
Cinacalcet—Asthenia—Dexamethasone—atopic dermatitis	0.00016	0.000847	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000159	0.000841	CcSEcCtD
Cinacalcet—Nausea—Prednisolone—atopic dermatitis	0.000159	0.000841	CcSEcCtD
Cinacalcet—Pruritus—Dexamethasone—atopic dermatitis	0.000158	0.000836	CcSEcCtD
Cinacalcet—Pruritus—Betamethasone—atopic dermatitis	0.000158	0.000836	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000157	0.00812	CbGpPWpGaD
Cinacalcet—Vomiting—Triamcinolone—atopic dermatitis	0.000156	0.000828	CcSEcCtD
Cinacalcet—Vomiting—Methylprednisolone—atopic dermatitis	0.000156	0.000826	CcSEcCtD
Cinacalcet—Nausea—Hydrocortisone—atopic dermatitis	0.000155	0.000821	CcSEcCtD
Cinacalcet—Rash—Triamcinolone—atopic dermatitis	0.000155	0.000821	CcSEcCtD
Cinacalcet—Dermatitis—Triamcinolone—atopic dermatitis	0.000155	0.00082	CcSEcCtD
Cinacalcet—Rash—Methylprednisolone—atopic dermatitis	0.000154	0.000819	CcSEcCtD
Cinacalcet—Dermatitis—Methylprednisolone—atopic dermatitis	0.000154	0.000818	CcSEcCtD
Cinacalcet—Urticaria—Prednisone—atopic dermatitis	0.000154	0.000817	CcSEcCtD
Cinacalcet—Headache—Triamcinolone—atopic dermatitis	0.000154	0.000816	CcSEcCtD
Cinacalcet—Headache—Methylprednisolone—atopic dermatitis	0.000153	0.000814	CcSEcCtD
Cinacalcet—Abdominal pain—Prednisone—atopic dermatitis	0.000153	0.000813	CcSEcCtD
Cinacalcet—Body temperature increased—Prednisone—atopic dermatitis	0.000153	0.000813	CcSEcCtD
Cinacalcet—Diarrhoea—Dexamethasone—atopic dermatitis	0.000152	0.000808	CcSEcCtD
Cinacalcet—Diarrhoea—Betamethasone—atopic dermatitis	0.000152	0.000808	CcSEcCtD
Cinacalcet—Dizziness—Betamethasone—atopic dermatitis	0.000147	0.000781	CcSEcCtD
Cinacalcet—Dizziness—Dexamethasone—atopic dermatitis	0.000147	0.000781	CcSEcCtD
Cinacalcet—Nausea—Triamcinolone—atopic dermatitis	0.000146	0.000773	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—CCL11—atopic dermatitis	0.000146	0.00756	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CMA1—atopic dermatitis	0.000146	0.00756	CbGpPWpGaD
Cinacalcet—Nausea—Methylprednisolone—atopic dermatitis	0.000145	0.000772	CcSEcCtD
Cinacalcet—Hypersensitivity—Prednisone—atopic dermatitis	0.000143	0.000758	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CXCL10—atopic dermatitis	0.000142	0.00737	CbGpPWpGaD
Cinacalcet—Vomiting—Dexamethasone—atopic dermatitis	0.000142	0.000751	CcSEcCtD
Cinacalcet—Vomiting—Betamethasone—atopic dermatitis	0.000142	0.000751	CcSEcCtD
Cinacalcet—Rash—Betamethasone—atopic dermatitis	0.00014	0.000745	CcSEcCtD
Cinacalcet—Rash—Dexamethasone—atopic dermatitis	0.00014	0.000745	CcSEcCtD
Cinacalcet—Dermatitis—Betamethasone—atopic dermatitis	0.00014	0.000744	CcSEcCtD
Cinacalcet—Dermatitis—Dexamethasone—atopic dermatitis	0.00014	0.000744	CcSEcCtD
Cinacalcet—Headache—Dexamethasone—atopic dermatitis	0.00014	0.00074	CcSEcCtD
Cinacalcet—Headache—Betamethasone—atopic dermatitis	0.00014	0.00074	CcSEcCtD
Cinacalcet—Asthenia—Prednisone—atopic dermatitis	0.000139	0.000738	CcSEcCtD
Cinacalcet—Pruritus—Prednisone—atopic dermatitis	0.000137	0.000728	CcSEcCtD
Cinacalcet—CASR—Signaling Pathways—STAT6—atopic dermatitis	0.000137	0.00711	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CCL5—atopic dermatitis	0.000135	0.00699	CbGpPWpGaD
Cinacalcet—Diarrhoea—Prednisone—atopic dermatitis	0.000133	0.000704	CcSEcCtD
Cinacalcet—Nausea—Dexamethasone—atopic dermatitis	0.000132	0.000702	CcSEcCtD
Cinacalcet—Nausea—Betamethasone—atopic dermatitis	0.000132	0.000702	CcSEcCtD
Cinacalcet—CASR—GPCR ligand binding—CXCL8—atopic dermatitis	0.00013	0.00673	CbGpPWpGaD
Cinacalcet—CASR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000129	0.00671	CbGpPWpGaD
Cinacalcet—Dizziness—Prednisone—atopic dermatitis	0.000128	0.00068	CcSEcCtD
Cinacalcet—Vomiting—Prednisone—atopic dermatitis	0.000123	0.000654	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCL5—atopic dermatitis	0.000122	0.00635	CbGpPWpGaD
Cinacalcet—Rash—Prednisone—atopic dermatitis	0.000122	0.000649	CcSEcCtD
Cinacalcet—Dermatitis—Prednisone—atopic dermatitis	0.000122	0.000648	CcSEcCtD
Cinacalcet—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000122	0.00632	CbGpPWpGaD
Cinacalcet—Headache—Prednisone—atopic dermatitis	0.000122	0.000644	CcSEcCtD
Cinacalcet—CASR—GPCR downstream signaling—CCR5—atopic dermatitis	0.000121	0.0063	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCR3—atopic dermatitis	0.000119	0.00616	CbGpPWpGaD
Cinacalcet—Nausea—Prednisone—atopic dermatitis	0.000115	0.000611	CcSEcCtD
Cinacalcet—CASR—Signaling by GPCR—CCR5—atopic dermatitis	0.00011	0.00572	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NPS—atopic dermatitis	0.000106	0.00549	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TAC1—atopic dermatitis	0.000106	0.00549	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CXCR3—atopic dermatitis	0.000104	0.00539	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL5—atopic dermatitis	9.85e-05	0.00511	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	9.41e-05	0.00488	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CXCL10—atopic dermatitis	8.4e-05	0.00435	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CXCL8—atopic dermatitis	7.34e-05	0.00381	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCL5—atopic dermatitis	7.23e-05	0.00375	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—IL2—atopic dermatitis	7.01e-05	0.00364	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NGF—atopic dermatitis	6.69e-05	0.00347	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CXCL8—atopic dermatitis	6.66e-05	0.00346	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCR5—atopic dermatitis	6.51e-05	0.00338	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	6.49e-05	0.00337	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL2—atopic dermatitis	6.37e-05	0.0033	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	5.79e-05	0.003	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	5.77e-05	0.00299	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NFKBIA—atopic dermatitis	5.52e-05	0.00286	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	4.2e-05	0.00218	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	4.2e-05	0.00218	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.94e-05	0.00205	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CXCL8—atopic dermatitis	3.94e-05	0.00204	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL2—atopic dermatitis	3.76e-05	0.00195	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL6—atopic dermatitis	3.74e-05	0.00194	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAPK8—atopic dermatitis	3.46e-05	0.0018	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL6—atopic dermatitis	2.21e-05	0.00115	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GLB1—atopic dermatitis	2.07e-05	0.00108	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ADSL—atopic dermatitis	1.99e-05	0.00103	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.76e-05	0.000911	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.68e-05	0.000873	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.36e-05	0.000703	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.3e-05	0.000674	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.28e-05	0.000664	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PPARA—atopic dermatitis	6.73e-06	0.000349	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PPARA—atopic dermatitis	5.7e-06	0.000296	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PPARA—atopic dermatitis	4.4e-06	0.000228	CbGpPWpGaD
